Quarterly Consolidated Statement Of Cash Flows

NANO MRNA Co.,Ltd. - Filing #7243707

Concept As at
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-03-31
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-430,257,000 JPY
-610,459,000 JPY
Income taxes paid
-2,383,000 JPY
-2,490,000 JPY
Net cash provided by (used in) operating activities
-401,617,000 JPY
-585,081,000 JPY
Cash flows from investing activities
Purchase of securities
-5,200,160,000 JPY
-5,800,000,000 JPY
Purchase of investment securities
-100,451,000 JPY
-200,000,000 JPY
Proceeds from sale of investment securities
JPY
140,055,000 JPY
Other, net
-3,982,000 JPY
-65,450,000 JPY
Net cash provided by (used in) investing activities
587,528,000 JPY
793,007,000 JPY
Cash flows from financing activities
Purchase of treasury shares
0 JPY
0 JPY
Purchase of shares of subsidiaries not resulting in change in scope of consolidation
-100,000 JPY
JPY
Net cash provided by (used in) financing activities
-568,775,000 JPY
3,728,000 JPY
Effect of exchange rate change on cash and cash equivalents
4,802,000 JPY
54,016,000 JPY
Net increase (decrease) in cash and cash equivalents
-378,061,000 JPY
265,670,000 JPY
Cash and cash equivalents
1,197,201,000 JPY
1,575,263,000 JPY
1,309,592,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.